Machine learning models for estimating counterfactuals in a single-arm inflammatory bowel disease study
DGX agentarXiv:2604.23465v1 Announce Type: new Abstract: Single-arm trials accelerate study timelines by reducing the number of patients that must be recruited for a concurrent control group. However, these de